https://www.novumpr.nl/2018/02/08/encorafenib-and-binimetinib-combination-treatment-demonstrates-33-6-month-median-overall-survival-os-in-patients-with-braf-mutant-melanoma-in-phase-3-columbus-trial/?utm_source=rss&utm_medium=rss&utm_campaign=encorafenib-and-binimetinib-combination-treatment-demonstrates-33-6-month-median-overall-survival-os-in-patients-with-braf-mutant-melanoma-in-phase-3-columbus-trial NovumPR press releases Thu, 08 Feb 2018 10:52:58 +0000 hourly 1 https://wordpress.org/?v=6.8.3